Dutasteride in localised prostate cancer management
February 1, 2012
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
Interpretation
Dutasteride could provide a beneficial adjunct to active surveillance for men with low-risk prostate cancer.
Dr. Myers talks about active surveillance versus watchful waiting for prostate cancer
December 20, 2011
Dr. Myers compares active surveillance and watchful waiting for prostate cancer in this 6:51 video. Click here to view.